ARTICLE | Clinical News
Oral omecamtiv mecarbil: Completed Phase II enrollment
March 23, 2015 7:00 AM UTC
Cytokinetics and Amgen completed enrollment of about 450 patients in the dose-expansion portion of the double-blind, placebo-controlled, international Phase II COSMIC-HF trial evaluating 25 or 50 mg o...